Vol. 6: Sued for Patent Infringement? – Here’s How the Litigation would Unfold –

2025.11.01
Unlike the United States—a country known for its litigious culture – Japan sees relatively few patent lawsuits. However, the situation is somewhat different in the life sciences sector. In May of this year, a high-profile p… 黒澤伸行

Vol. 5: Do they really creep in? – Development schedules of Generics and Biosimilars

2025.09.30
This time, we are going to talk about generic drugs and biosimilars. These days in Japan we don't hear the word "zoro", but up until about 20 years ago, generic drugs were commonly referred to as "zoro." The word “zoro” stems … 黒澤伸行

Vol. 4: What do you mean “patents can be extended”? – Patent Term Extension: A special system for pharma–

2025.09.01
Last time, we discussed how to obtain a patent, following the process from application to obtaining a patent. I touched on the length of a patent term at the end. Do you remember how long a patent term was? The answer is 20… 黒澤伸行

Vol. 3: Shall we talk about how to obtain a patent? – Process flow from patent application to obtaining a patent –

2025.07.31
So far, we’ve explored the medicine classification and patents (Vol. 1), and the reasons why Medicines and Patents are inseparable (Vol. 2). In this volume, the spotlight fa… 黒澤伸行

Vol. 2: Wow! The success rate of drug development is shockingly low!

2025.07.01
In the previous volume, we discussed the types of pharmaceutical medicines and patents, so you will remember that “new drugs” are brand drugs under the category of ethical drugs… 黒澤伸行

Vol. 1: First, let’s talk about medicine classification and patents

2025.05.30
Most people understand that patents are important in the life sciences industry, including pharmaceuticals and biotechnology. However, many might feel that the complexities of patents make them difficult … 黒澤伸行

Quebec Life Science Companies and Organizations to Exhibit at BioJapan 2025

2025.09.22
From October 8 (Wed) to 10 (Fri), 2025, ten life science companies and organizations from Quebec, Canada will visit Japan to participate in BioJapan 2025!Booth: B-111. This is a unique ... 黒澤伸行

Pharma Nexus to Exhibit at JASIS 2025｜Showcasing the Latest Life Sciences Insights at Hall 7, LS-7

2025.09.02
Pharma Nexus, an information-sharing platform specializing in the life sciences,will be exhibiting at JASIS 2025 (Japan Analytical & Scientific Instruments Show),held at Makuhari… 黒澤伸行

Highlights of JASIS 2025

2025.07.23
I am Hisashi Iwase, Advisor for Life Science Innovation at the Japan Analytical Instruments Manufacturers’ Association (JAIMA), and President & CEO of BioDiscovery Inc.In the latter half of the 20th century, chromatographic… 黒澤伸行

77th Annual Meeting of the Society for Biotechnology, Japan (SBJ): Introduction to the SBJ-JAIMA Joint Pitch & Networking Session

2025.08.26
My name is Hisashi Iwase, Life Science Innovation Advisor at the Japan Analytical Instruments Manufacturers’ Association (JAIMA) and President & CEO of BioDiscovery Inc.The Japan Analytical Instruments Manufacturers’ Association (JAIMA) has collaborated with the Society for Biotechnology, Japan (SBJ) to develop innovative industry-academia initiatives, mainly throu… 黒澤伸行

M	T	W	T	F	S	S
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

Pharma Nexus

Vol. 6: Sued for Patent Infringement? – Here’s How the Litigation would Unfold –

Vol. 5: Do they really creep in? – Development schedules of Generics and Biosimilars

Vol. 4: What do you mean “patents can be extended”? – Patent Term Extension: A special system for pharma–

Vol. 3: Shall we talk about how to obtain a patent? – Process flow from patent application to obtaining a patent –

Vol. 2: Wow! The success rate of drug development is shockingly low!

Vol. 1: First, let’s talk about medicine classification and patents

Quebec Life Science Companies and Organizations to Exhibit at BioJapan 2025

Pharma Nexus to Exhibit at JASIS 2025｜Showcasing the Latest Life Sciences Insights at Hall 7, LS-7

Highlights of JASIS 2025

77th Annual Meeting of the Society for Biotechnology, Japan (SBJ): Introduction to the SBJ-JAIMA Joint Pitch & Networking Session

Recent Posts

Event Schedule

calender

Popular Posts

Pharma Nexus

Vol. 6: Sued for Patent Infringement? – Here’s How the Litigation would Unfold –

Vol. 5: Do they really creep in? – Development schedules of Generics and Biosimilars

Vol. 4: What do you mean “patents can be extended”? – Patent Term Extension: A special system for pharma–

Vol. 3: Shall we talk about how to obtain a patent? – Process flow from patent application to obtaining a patent –

Vol. 2: Wow! The success rate of drug development is shockingly low!

Vol. 1: First, let’s talk about medicine classification and patents

Quebec Life Science Companies and Organizations to Exhibit at BioJapan 2025

Pharma Nexus to Exhibit at JASIS 2025｜Showcasing the Latest Life Sciences Insights at Hall 7, LS-7

Highlights of JASIS 2025

77th Annual Meeting of the Society for Biotechnology, Japan (SBJ): Introduction to the SBJ-JAIMA Joint Pitch & Networking Session

Recent Posts

Tag Cloud

Event Schedule

calender

Popular Posts